Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 1/20 | 0.56 |
| ▸ | PRKCG | P05129 | 1/20 | 0.56 |
| ▸ | PRKCB | P05771 | 1/20 | 0.56 |
| ▸ | PRKCA | P17252 | 1/20 | 0.56 |
| ▸ | PRKCH | P24723 | 1/20 | 0.56 |
| ▸ | PRKCI | P41743 | 1/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.56 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.56 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.56 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.56 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.56 |
| ▸ | CD209 | Q9NNX6 | 3/20 | 0.51 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 1/20 | 0.50 |
| ▸ | ALPL | P05186 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3516599 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL12030336 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL3924682 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL2300084 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14217500 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL18328428 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL13851827 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL16186721 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8254322 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL1923753 | 1.00 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3566580-B1 | USE OF AN EXTRACT OR AN EXTRACT FRACTION OF AGAROPHYTE RED ALGAE AS A PLANT DEFENSE ELICITOR/STIMULATOR AND APPLICATION OF SAID EXTRACT OR SAID EXTRACT FRACTION | SOC DETUDE ET DEXPLOITATION DALGUES ET PRODUITS MARITIMES SETEXAM (MA) | 2023-07-05 | — | — | EP | claimed |
| US-20230205950-A1 | AI SIMULATION FOR MICROALGAE FERMENTATION | Sophie's BioNutrients Pte. Ltd. (SG) | 2023-06-29 | — | — | US | claimed |
| EP-4150046-A1 | IMPROVED BIOREACTOR SYSTEM FOR CULTIVATING MICROALGAE | Sophie's Bionutrients Pte. Ltd. (SG) | 2023-03-22 | — | — | EP | claimed |
| WO-2023031839-A2 | USING MIXOTROPHIC MICROALGAE TO PRODUCE CULTURED MEAT AND SEAFOOD | SOPHIE'S BIONUTRIENTS PTE LTD. (SG) | 2023-03-09 | — | — | WO | claimed |
| US-20220370322-A1 | UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND | ATHENA CO., LTD. (KR) | 2022-11-24 | — | — | US | claimed |
| EP-4085895-A1 | UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND | Athena Co., Ltd. (KR) | 2022-11-09 | — | — | EP | claimed |
| CN-114868954-A | Tobacco humectant and method for improving tobacco moistening feeling | 上海龙殷生物科技有限公司 | 2022-08-09 | — | — | CN | claimed |
| WO-2022144796-A1 | AI SIMULATION FOR MICROALGAE FERMENTATION | Sophie's BioNutrients Pte. Ltd. (SG) | 2022-07-07 | — | — | WO | claimed |
| CN-110447662-B | Use and application of red algae-brassica plant extract and extract fraction as plant defense inducer/stimulant | 海藻与海洋产品研究开发公司 | 2022-04-26 | — | — | CN | claimed |
| CN-114196690-A | Fluorodorside anabolism combined gene and combined enzyme | 中国海洋大学 | 2022-03-18 | — | — | CN | claimed |
| EP-1259619-A2 | VARIANT GALACTOSE OXIDASE, NUCLEIC ACID ENCODING SAME, AND METHODS OF USING SAME | HERCULES INCORPORATED (US) | 2002-11-27 | — | — | EP | claimed |
| US-20010051369-A1 | Variant galactose oxidase, nucleic acid encoding same, and methods of using same | HERCULES INCORPORATED | 2001-12-13 | — | — | US | claimed |
| WO-2001062938-A2 | VARIANT GALACTOSE OXIDASE, NUCLEIC ACID ENCODING SAME, AND METHODS OF USING SAME | HERCULES INCORPORATED (US) | 2001-08-30 | — | — | WO | claimed |
| US-12600994-B2 | β-ketoacyl-ACP synthase IV variants | CORBION BIOTECH, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| EP-4717255-A1 | GRATELOUPIA TURUTURU EXTRACT AND COSMETIC USE THEREOF | Laboratoires Gilbert (FR) | 2026-04-01 | — | — | EP | disclosed |
| US-12540305-B2 | Method of culturing algae | THE UNIVERSITY OF SHEFFIELD (GB) | 2026-02-03 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| EP-0729648-A4 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LTD (AU) | 1997-01-02 | — | — | EP | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600994-B2 | β-ketoacyl-ACP synthase IV variants | COASY, PSAT1, ACAT2 | PRKD3 1527/4885PRKCG 590/4885PRKCB 565/4885 |
| US-20220370322-A1 | UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND | FLNB, PARG, FUCA1 | PRKD3 2765/4885PRKCG 1713/4885PRKCB 2351/4885 |
| US-12540305-B2 | Method of culturing algae | CRY1, PPOX, G6PD | PRKD3 2581/4885PRKCG 2128/4885PRKCB 1250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.